![]() Read the news brief for more information. There is no cost for appeals related to COVID-19 in this pilot program, which starts on April 15, 2021. On April 14, the United States Patent and Trademark Office (USPTO) announced that the Patent Trial and Appeal Board (PTAB) will soon accept petitions for expedited resolution of ex parte appeals for COVID-related inventions. See the full text of the notice for more information. There are no additional fees or requirements for applicants to meet to be involved in the relief offered. TTAB is monitoring the eligible applications. Under a Conference Pilot Program for Oppositions Against Applications Related to COVID-19, a TTAB attorney or judge may participate in the parties’ mandatory settlement and discovery planning conference. Under a Pilot Prioritized Review Program for Appeals Related to COVID-19, TTAB will expedite the review of, and the issuance of ex parte appeal decisions under certain circumstances. The United States Patent and Trademark Office (USPTO) is offering relief for applications on appeal or involved in an opposition before the Trademark Trial and Appeal Board (TTAB) if the applications were examined under the USPTO’s COVID-19 Prioritized Trademark Examination Program. Relief for COVID-19 Prioritized Trademark Examination Program applications on appeal or in oppositions before the TTAB As a conforming change, this final rule also removes § 1.6(d)(1) to eliminate an obsolete cross reference to § 1.4(e). Elimination of § 1.4(e) allows, for example, the use of facsimile transmissions and S-signatures, and facilitates implementation of an electronic filing system within the OED. The removal of § 1.4(e) makes permanent the USPTO’s waiver of these signature requirements published in the Federal Register on Ma( 85 FR 17502). Section 1.4(e) required original handwritten signatures in dark ink on correspondence relating to (1) registration to practice before the Office and other matters within the purview of the Office of Enrollment and Discipline (OED), and (2) payments by credit card where the payment is not being made via the Office’s electronic filing systems. The United States Patent and Trademark Office (USPTO) is eliminating the handwritten signature requirement set forth in 37 CFR § 1.4(e) by a final rule, effective July 2, 2021. USPTO announces final rule to eliminate handwritten signature requirement ![]() In communities with high transmission levels, wearing a mask in our buildings is mandatory. Please check the CDC’s levels and our office location pages for details, including which services are now being provided in-person as well as virtually. ![]() In communities with low or medium transmission levels, wearing a mask in our buildings is optional. We continue to monitor local conditions for all locations as determined by the Center for Disease Control’s (CDC) COVID-19 community levels. Visitors should review this health questionnaire prior to entering and may not enter facilities if they answer "yes" to any of the questions. On May 25, 2022, the United States Patent and Trademark Office (USPTO) fully reopened all locations to employees and resumed some in-person events and appointments for the public. Updates from the United States Patent and Trademark Office during the COVID-19 coronavirus outbreak.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |